Understanding the regulatory mechanisms that control Nrf2 protein levels, along with the molecular mechanisms of UPS and autophagy, will guide future development of Nrf2-targeted therapeutics in AMD [8]. This evidence concerns the gene NFE2L2 and age-related macular degeneration.